Accelerated Aging & Senescence Organoid Modeling Service

Aging is the most significant risk factor for prevalent neurodegenerative diseases, yet modeling the intricate processes of brain aging in a human-relevant context remains a major scientific hurdle. Standard human induced pluripotent stem cell (hiPSC)-derived brain organoids recapitulate early neurodevelopment, creating a "development-versus-aging" gap. This fundamental limitation has hindered the investigation of late-onset cellular hallmarks, such as senescence, chronic inflammation, and metabolic decline, which are central to the pathology of age-related brain disorders.

Creative Biolabs confronts this challenge with a pioneering Accelerated Aging and Senescence Organoid Modeling Service. We have developed a comprehensive suite of protocols to precisely induce and meticulously analyze aging phenotypes in 3D human brain organoids. Our platforms offer an unparalleled window into the molecular mechanisms of brain aging, enabling the discovery and validation of next-generation neuroprotective drugs and novel senotherapeutics.

Our Versatile Toolbox for Inducing and Modeling Brain Aging

We offer a multi-pronged approach to generate physiologically relevant aged organoid models, allowing you to select the optimal system to address your specific research questions.

1. Chemically-Induced Premature Senescence (SIPS): To rapidly model the effects of cumulative cellular stress, we employ established chemical induction methods. By treating organoids with agents such as D-galactose, hydrogen peroxide (H₂O₂), or other oxidative stressors, we can efficiently provoke a robust senescent phenotype.
2. Genetic Modeling of Aging Pathways: To dissect the function of specific longevity pathways, we utilize advanced CRISPR-Cas9 gene editing. We can generate models with targeted knockouts of key aging regulators, such as SIRT1 or Klotho, providing a highly controlled system to investigate their direct impact on the aging cascade.
3. Modeling Progeroid Syndromes: We leverage patient-derived iPSCs from individuals with premature aging syndromes (e.g., Hutchinson-Gilford, Ataxia-Telangiectasia) to create models that faithfully recapitulate the genetic drivers of accelerated aging.
4. Long-Term Culture for Intrinsic Aging: We maintain brain organoids in extended culture protocols to observe the natural emergence of aging phenotypes. This approach is ideal for longitudinal studies tracking the gradual accumulation of senescent cells and age-related biomarkers.

Comprehensive Phenotyping & Mechanistic Readouts of Brain Aging

Our aged organoid models are subjected to rigorous, multi-parametric analysis to provide a comprehensive profile of the aging phenotype. We offer a suite of validated readouts that connect observable cellular changes to their underlying molecular drivers.

1. Core Hallmarks of Cellular Senescence: We provide definitive identification of senescent cells through multiple assays. This includes quantification of Senescence-Associated β-galactosidase (SA-β-gal) activity and the expression analysis of key cell-cycle inhibitors like p16(INK4a) and p21. This is complemented by assessing the DNA Damage Response (DDR) via immunofluorescent quantification of γH2AX foci, providing a robust measure of genomic instability.
2. Analysis of Key Aging-Related Signaling Pathways: We don't just observe aging; we dissect its drivers. Our platform allows for the functional investigation of critical longevity pathways, including:
   • mTOR Signaling: Measuring pathway activity and its modulation by specific inhibitors like Rapamycin.
   • NAD+/SIRT1 Axis: Assessing changes in this core metabolic pathway and its response to interventions like NAD+ precursors (NMN, NR).
   • Wnt/β-catenin Signaling: Investigating the role of this developmental pathway in age-related stem cell decline.
3. Characterization of Neuro-Inflammaging and the SASP: We quantify the pro-inflammatory microenvironment driven by senescent cells. This involves a full analysis of the Senescence-Associated Secretory Phenotype (SASP), profiling the secretion of key cytokines and chemokines such as IL-6 and CCL2. This readout is critical for testing senomorphic compounds and understanding the link between cellular senescence and chronic, sterile inflammation via pathways like cGAS-STING.
4. Mitochondrial Dysfunction and Metabolic Decline: We assess the energetic health of the aged organoids by evaluating mitochondrial morphology, membrane potential, and the accumulation of oxidative stress markers, providing insight into age-related metabolic failure.
5. Pathological Protein Aggregation: In the context of age-related neurodegenerative diseases, we provide quantitative analysis of signature pathological proteins. This includes measuring the burden of amyloid-β plaques and hyperphosphorylated Tau tangles in our Alzheimer's disease models, directly linking the aging environment to disease-specific pathology.

Our Workflow

From Cellular Aging to Therapeutic Rejuvenation. Redefine the Possibilities in Neuro-Gerontology.

Partner with Creative Biolabs to leverage our advanced human organoid platforms. Dissect the mechanisms of brain aging and accelerate the discovery of therapies that can extend healthspan.

Consult Our Aging & Senescence Specialists